Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure

Anacor Pharmaceuticals, Inc. (ANAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/24/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/24/2016 4 Shapiro Lucy (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 89,000 shares @ $99.25, valued at $8.8M
Disposed/sold 853 shares @ $99.25, valued at $84.7k
Disposed/sold 4,403 options to buy @ $69.4, valued at $305.6k
06/24/2016 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 794 shares @ $99.25, valued at $78.8k
Disposed/sold 30,000 options to buy @ $6.92, valued at $207.6k
Disposed/sold 24,000 options to buy @ $6.74, valued at $161.8k
Disposed/sold 15,000 options to buy @ $5.2, valued at $78k
Disposed/sold 15,000 options to buy @ $5.11, valued at $76.7k
Disposed/sold 15,000 options to buy @ $14.22, valued at $213.3k
Disposed/sold 4,096 options to buy @ $69.4, valued at $284.3k
06/24/2016 4 Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 WIERENGA WENDALL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 794 shares @ $99.25, valued at $78.8k
Disposed/sold 27,000 options to buy @ $25.48, valued at $688k
Disposed/sold 4,096 options to buy @ $69.4, valued at $284.3k
06/24/2016 4 Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/03/2016 4 Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
05/24/2016 4 Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
05/18/2016 4 Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
04/29/2016 4 Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
04/15/2016 4 Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
04/11/2016 4 Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
04/04/2016 4 RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Exercised 30,000 shares @ $6.92, valued at $207.6k
Exercised 7,500 shares @ $6.74, valued at $50.6k
Exercised 12,500 shares @ $5.2, valued at $65k
Exercised 15,000 shares @ $5.11, valued at $76.7k
Exercised 24,000 shares @ $14.22, valued at $341.3k
Exercised 30,000 options to buy @ $6.92, valued at $207.6k
Exercised 7,500 options to buy @ $6.74, valued at $50.6k
Exercised 12,500 options to buy @ $5.2, valued at $65k
Exercised 15,000 options to buy @ $5.11, valued at $76.7k
Exercised 24,000 options to buy @ $14.22, valued at $341.3k
03/22/2016 4 BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Sold 9,700 shares @ $59.8903, valued at $580.9k
Sold 27,800 shares @ $60.4561, valued at $1.7M
03/04/2016 4 IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
02/05/2016 4 Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 4,375 shares @ $0
Granted 22,136 options to buy @ $78.91, valued at $1.7M
Granted 4,375 options to buy @ $0
02/05/2016 4 IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 5,000 shares @ $0
Granted 25,299 options to buy @ $78.91, valued at $2M
Granted 5,000 options to buy @ $0
02/05/2016 4 Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 6,250 shares @ $0
Granted 31,623 options to buy @ $78.91, valued at $2.5M
Granted 6,250 options to buy @ $0
02/05/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/05/2016 4 Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
11/08/2013 4 Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
11/08/2013 4 Chanda Sanjay (SVP, Drug Development) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
10/04/2013 4 Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
08/14/2013 4 Maples Kirk R (SVP, Program Management) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
08/13/2013 4 Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/19/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/18/2013 4 Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/10/2013 4 Hove Anders D (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/07/2013 4 KLINGENSTEIN PAUL H (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy